[1]
“Efficacy and safety of anlotinib in patients with advanced colorectal cancer and analysis of prognostic factors”, Indian J Exp Biol, vol. 59, no. 10, pp. 740–744, Oct. 2021, doi: 10.56042/ijeb.v59i10.55805.